Botanical species · safety record
Ammi visnaga
The EFSA Compendium of Botanicals holds 18 constituent measurements and 1 adverse-effect record for Ammi visnaga. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Ammi visnaga (L.) Lam.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 21 licensed products naming Ammi visnaga as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Source material stated
What the records describe
Constituents measured
- Khellin6
- Visnagine5
- Coumarins3
- Daidzein1
- Formononetin1
- Genistein1
- Marmesin1
Plant parts
- Fruit unspecified11
- Seed6
- Flowering top2
Preparations
- Solvent extraction16
Effect types
- Hepatotoxicity1
Target tissues
- Digestive1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Coumarins | Fruit unspecified | Solvent extraction | ≤ 1.84 Percent | Chromatographic tests | Resolve DOI |
| Coumarins | Fruit unspecified | Solvent extraction | ≥ 1.11 Percent | Chromatographic tests | Resolve DOI |
| Khellin | Fruit unspecified | Solvent extraction | ≥ 0.75 Percent | Chromatographic tests | Resolve DOI |
| Khellin | Seed | Solvent extraction | 361.9 Milligram/gram | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Khellin | Fruit unspecified | Solvent extraction | ≤ 3.03 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Khellin | Fruit unspecified | Solvent extraction | ≥ 2.27 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Khellin | Fruit unspecified | Solvent extraction | 1 Microgram/millilitre | Chromatographic tests | Resolve DOI |
| Khellin | Fruit unspecified | Solvent extraction | ≤ 1.01 Percent | Chromatographic tests | Resolve DOI |
| Visnagine | Seed | Solvent extraction | 235.7 Milligram/gram | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Visnagine | Fruit unspecified | Solvent extraction | ≤ 1.28 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Visnagine | Fruit unspecified | Solvent extraction | ≥ 0.93 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Visnagine | Fruit unspecified | Solvent extraction | ≤ 0.46 Percent | Chromatographic tests | Resolve DOI |
| Visnagine | Fruit unspecified | Solvent extraction | ≥ 0.18 Percent | Chromatographic tests | Resolve DOI |
| Coumarins | Flowering top | — | — | Element spectroscopy | No resolvable identifier |
| Daidzein | Seed | Solvent extraction | 62.4 Milligram/kilogram | UHPLC-MS-MS | No resolvable identifier |
| Formononetin | Seed | Solvent extraction | 6.2 Milligram/kilogram | UHPLC-MS-MS | No resolvable identifier |
| Genistein | Seed | Solvent extraction | 23 Milligram/kilogram | UHPLC-MS-MS | No resolvable identifier |
| Marmesin | Flowering top | — | — | Element spectroscopy | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Hepatotoxicity | Digestive | Seed | — | Gallus gallus (chicken) (as animal) | Subchronic | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Ibrahim, IA., ElBadwi, SMA., Gadir, WSA., Bakhiet, AO., Yagoub, SO., Adam, SEI. Susceptibility of Bovans chicks to low dietary levels of Ammi visnaga and Artemisia herba-alba . Veterinary and human toxicology, 2004, vol. 46, no. 2, p. 67-69.
- Abdulmanea, Khaled., Prokudina, Elena A., Lankova, Petra., Vanickova, Lucie., Koblovska, Radka., Zeleny, Vaclav., Lapcik, Oldrich. Immunochemical and HPLC identification of isoflavonoids in the Apiaceae family.. Biochemical systematics and ecology, 2012, vol. 45, p. 237-243.
- Baddar, F.G., Farid, S., Starkovsky, N.A. The coumarins of ammi visnaga L. Part I. Their reactions with benzene, toluene, and anisole in presence of aluminium chloride: Isolation of minor constituents of ammi visnaga. Journal of the chemical society (resumed), 1963, p. 4598-4600.
- Winderl, Bianca., Schwaiger, Stefan., Ganzera, Markus. Fast and improved separation of major coumarins in Ammi visnaga (L.) Lam. by supercritical fluid chromatography . Journal of separation science, 2016, vol. 39, no. 20, p. 4042-4048. DOI
- Pavela, Roman., Vrchotova, Nadezda., Triska, Jan. Larvicidal activity of extracts from Ammi visnaga Linn. (Apiaceae) seeds against Culex quinquefasciatus Say. (Diptera: Culicidae) . Experimental parasitology, 2016, vol. 165, p. 51-57. DOI
- Zgorka, G., Dragan, T., Glowniak, K., Basiura, E. Determination of furanochromones and pyranocoumarins in drugs and Ammi visnaga fruits by combined solid-phase extraction-high-performance liquid chromatography and thin-layer chromatography-high-performance liquid chromatography . Journal of chromatography a, 1998, vol. 797, no. 1-2, p. 305-309. DOI
- Schimmer, O., Rauch, P. Inhibition of metabolic activation of the promutagens, benzo a pyrene, 2-aminofluorene and 2-aminoanthracene by furanochromones in Salmonella typhimurium . Mutagenesis, 1998, vol. 13, no. 4, p. 385-389. DOI
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.